242 related articles for article (PubMed ID: 32130965)
1. Choice of Surgical Options in Kidney Cancer and Surgical Complications.
Wasserman M; Sobel D; Pareek G
Semin Nephrol; 2020 Jan; 40(1):42-48. PubMed ID: 32130965
[TBL] [Abstract][Full Text] [Related]
2. A robotic-assisted laparoscopic approach for pediatric renal cell carcinoma allows for both nephron-sparing surgery and extended lymph node dissection.
Cost NG; Geller JI; DeFoor WR; Wagner LM; Noh PH
J Pediatr Surg; 2012 Oct; 47(10):1946-50. PubMed ID: 23084214
[TBL] [Abstract][Full Text] [Related]
3. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
Long JA; Bernhard JC; Bigot P; Lanchon C; Paparel P; Rioux-Leclercq N; Albiges L; Bodin T; Nouhaud FX; Boissier R; Gimel P; Méjean A; Masson-Lecomte A; Grenier N; Cornelis F; Grassano Y; Comat V; Le Clerc QC; Rigaud J; Salomon L; Descotes JL; Sengel C; Roupret M; Verhoest G; Ouzaid I; Arnoux V; Bensalah K;
World J Urol; 2017 Apr; 35(4):649-656. PubMed ID: 27498139
[TBL] [Abstract][Full Text] [Related]
4. [Nephron-sparing treatments for kidney cancer].
Casuscelli J; Fischereder M; Gratzke C; Staehler M; Stief CG
MMW Fortschr Med; 2012 Dec; 154(22):45-6, 48. PubMed ID: 23297539
[No Abstract] [Full Text] [Related]
5. Robotic Retrocaval Metastasectomy After an Ipsilateral Radical Nephrectomy.
Nelson RJ; Reese JH; Babbar P; Kaouk JH
Urology; 2017 Sep; 107():270. PubMed ID: 28982624
[TBL] [Abstract][Full Text] [Related]
6. Current status and advances in nephron-sparing surgery.
Fergany A
Clin Genitourin Cancer; 2006 Jun; 5(1):26-33. PubMed ID: 16859576
[TBL] [Abstract][Full Text] [Related]
7. [Nephron-sparing therapy for renal tumors].
Brehmer B; Mahnke AH; Jakse G
Aktuelle Urol; 2007 Mar; 38(2):126-31; discussion 125. PubMed ID: 17390274
[TBL] [Abstract][Full Text] [Related]
8. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
[TBL] [Abstract][Full Text] [Related]
9. Oncological outcomes of nephron sparing nephrectomy. 17-year analysis.
Aguilera Bazan A; Bañuelos B; Alonso-Dorrego JM; Diez J; Cisneros J; De la Peña Barthel J
Arch Esp Urol; 2014 Apr; 67(3):237-42. PubMed ID: 24840588
[TBL] [Abstract][Full Text] [Related]
10. Minimally Invasive Surgery for Patients with Locally Advanced and/or Metastatic Renal Cell Carcinoma.
Becher E; Jericevic D; Huang WC
Urol Clin North Am; 2020 Aug; 47(3):389-397. PubMed ID: 32600540
[TBL] [Abstract][Full Text] [Related]
11. Changing concepts in the surgical management of renal cell carcinoma.
Lam JS; Shvarts O; Pantuck AJ
Eur Urol; 2004 Jun; 45(6):692-705. PubMed ID: 15149740
[TBL] [Abstract][Full Text] [Related]
12. [Standard surgery for small renal masses (<4 cm)].
Frees SK; Mager R; Borgmann H; Jäger W; Thomas C; Haferkamp A
Urologe A; 2018 Mar; 57(3):280-284. PubMed ID: 29468282
[TBL] [Abstract][Full Text] [Related]
13. Editorial: 'nephron-sparing surgery for renal cancers'.
Klatte T
Curr Opin Urol; 2014 Sep; 24(5):435-6. PubMed ID: 25004392
[No Abstract] [Full Text] [Related]
14. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
15. Emerging surgical treatments for renal cell carcinoma.
Husain FZ; Badani KK; Sfakianos JP; Mehrazin R
Future Oncol; 2016 Apr; 12(7):921-9. PubMed ID: 26892144
[TBL] [Abstract][Full Text] [Related]
16. Update on contemporary management of clinically localized renal cell carcinoma.
Jorns JJ; Thiel DD; Castle EP
Minerva Urol Nefrol; 2012 Dec; 64(4):261-72. PubMed ID: 23288213
[TBL] [Abstract][Full Text] [Related]
17. American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy.
Secin FP; Castillo OA; Rozanec JJ; Featherston M; Holst P; Milfont JC; García Marchiñena P; Jurado Navarro A; Autrán A; Rovegno AR; Faba OR; Palou J; Teixeira Dubeux V; Nuñez Bragayrac L; Sotelo R; Zequi S; Guimarães GC; Álvarez-Maestro M; Martínez-Piñeiro L; Villoldo G; Villaronga A; Abreu Clavijo D; Decia R; Frota R; Vidal-Mora I; Finkelstein D; Monzó Gardiner JI; Schatloff O; Hernández-Porrás A; Santaella-Torres F; Quesada ET; Sánchez-Salas R; Dávila H; Mavric HV
World J Urol; 2017 Jan; 35(1):57-65. PubMed ID: 27137994
[TBL] [Abstract][Full Text] [Related]
18. Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience.
De Gobbi A; Biasoni D; Catanzaro M; Nicolai N; Piva L; Stagni S; Torelli T; Procopio G; Verzoni E; Grassi P; Colecchia M; Paolini B; Spreafico C; Marchianò A; Salvioni R
Tumori; 2018 Oct; 104(5):388-393. PubMed ID: 28085177
[TBL] [Abstract][Full Text] [Related]
19. A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project).
Schiavina R; Mari A; Antonelli A; Bertolo R; Bianchi G; Borghesi M; Brunocilla E; Fiori C; Longo N; Martorana G; Mirone V; Morgia G; Novara G; Porpiglia F; Rovereto B; Serni S; Simeone C; Sodano M; Terrone C; Carini M; Minervini A
Eur J Surg Oncol; 2015 Mar; 41(3):346-52. PubMed ID: 25583459
[TBL] [Abstract][Full Text] [Related]
20. Trend of Surgical Treatment of Localized Renal Cell Carcinoma.
Jabaji RB; Fischer H; Kern T; Chien GW
Perm J; 2019; 23():18-108. PubMed ID: 30624203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
